RN

Rajeev Nayyar

Active Director Director DIN 01398509
DIN 01398509 First appointment Jul 1990 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 1990
Shareholding value •••• Premium profile

About Rajeev Nayyar

Data last updated:

Rajeev Nayyar is a Director at Gems Drugs Private Limited (since 1990). The company operates in Chemicals. Gems Drugs Private Limited reported revenue of ₹21.9 Lakh (FY 2025).

DIN 01398509
Primary Designation Director
Industry Chemicals
First Appointment 13 Jul 1990
Oldest Company Age 36 yrs
Largest company Gems Drugs Private Limited · ₹21.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gems Drugs Private Limited U24232DL1990PTC040668
Director13 Jul 19901990₹21.9 Lakh (FY 2025)Active

Board colleagues of Rajeev Nayyar

NameDINCompanyDesignation
Ritu Nayyar01758124Gems Drugs Private LimitedDirector
Sahil Nayyar05139485Gems Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gems Drugs Private Limited
Premium access

Shareholding and investment profile for Rajeev Nayyar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Nayyar

Rajeev Nayyar currently holds 1 directorship: Gems Drugs Private Limited (Director, since 13 Jul 1990, revenue ₹21.9 Lakh (FY 2025)).

Rajeev Nayyar was first appointed on 13 Jul 1990 as Director at Gems Drugs Private Limited.

The current boards of Rajeev Nayyar's companies include Ritu Nayyar (Gems Drugs Private Limited), Sahil Nayyar (Gems Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available